Hardman & Co Research: Q&A with Mark Thomas on Arbuthnot Banking Group (ARBB): 2020 interim results: credit robust, rate sensi.

31.07.20 09:45

Hardman & Co Research
Hardman & Co Research: Q&A with Mark Thomas on Arbuthnot Banking Group (ARBB): 2020 interim results: credit robust, rate sensitivity

31-Jul-2020 / 08:40 GMT/BST

Hardman & Co Research: 2020 interim results: credit robust, rate sensitivity

Arbuthnot Banking Group (ARBB) is the topic of conversation when DirectorsTalk caught up with Mark Thomas. Mark talks us through the key takeaways from Arbuthnot's recent interim results, and tells us more about its structural resilience and the impact of base-rate cuts and COVID-19-related provisions.

Please click on the link below to listen to the interview:


If you are interested in meeting the company, you can register your interest by clicking on the above link

To contact us:

Hardman & Co
35 New Broad Street


Follow us on Twitter @HardmanandCo


Mark Thomas

+44 20 7194 7622



Hardman & Co Research can still be accessed for free after MiFID II. Please click here to read the statement.

About Hardman & Co: For the past 25 years Hardman has been producing specialist research designed to improve investors' understanding of companies, sectors, industries and investment securities. Our Analysts are highly experienced in their sectors, and have often been highly rated by professional investors for their knowledge.  Our focus is to raise companies' profiles across the UK and abroad with outstanding research, investor engagement programmes and advisory services. Some of our notes have been commissioned by the company which is the subject of the note; this is clearly stated in the disclaimer where this is the case.

Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843. Hardman Research Ltd is registered at Companies House with number 8256259.

Our research is provided for the use of the professional investment community, market counterparties and sophisticated and high net worth investors as defined in the rules of the regulatory bodies.  It is not intended to be made available to unsophisticated retail investors. Anyone who is unsure of their categorisation should consult their professional advisors. This research is neither an offer, nor a solicitation, to buy or sell any security. Please read the note for the full disclaimer.


Dissemination of a CORPORATE NEWS, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.

End of Announcement - EQS News Service

1106927  31-Jul-2020 



Breaking News

Kurs- und weitere Informationen zum Thema:

Arbuthnot Banking

Aktuelle Diskussionen zum Thema:

Aktuelle Nachrichten zum Unternehmen:

Arbuthnot Banking: Bitte nicht ver. (19.09.21)
Arbuthnot BankingSollten Anleger . (16.09.21)
Arbuthnot Banking: Aufschrei, gar. (03.09.21)
Arbuthnot Banking: Selbst wir hab. (17.08.21)
Arbuthnot Banking: Kann es das w. (30.07.21)

Alle Nachrichten zum Unternehmen

Aktuelle Analysen zu den Unternehmen:

Arbuthnot Banking
Weitere Meldungen
31.07 SphingoTec to Present at th.
31.07 Marshal Lion Financial Group.
31.07 Directors' Dealings: FCR Imm.
31.07 ADM Energy PLC: Appointm.
31.07 Logwin AG: Logwin angesic.
31.07 Eve Sleep plc: Holding in Co.
31.07 Stimmrechtsanteile: Epigenom.
31.07 Zulassungsfolgepflichten: Lin.
31.07 Directors' Dealings: Baader B.
31.07 Directors' Dealings: ADVA .
31.07 MediCoronabedingt vorsorglic.
31.07 Directors' Dealings: ADVA .
31.07 Stimmrechtsanteile: Philion S.
31.07 EQS-News: Nordea Bank Ab.
31.07 Directors' Dealings: Baader B.
31.07 132 Berufseinsteiger starten.
31.07 DGAP-NVR: Fresenius SE &.
31.07 Veränderungen im Vorstand .
31.07 Stimmrechtsanteile: MorphoSy.
31.07 Baumot Group veröffentlicht .
31.07 Benjamin Schmid ab August.
31.07 Hardman & Co Research: Q.
31.07 KERAMUNDO: Handelsblatt: .
31.07 OTI Greentech AG: OTI Gre.
31.07 CR Capital Real Estate AG.
31.07 Directors' Dealings: Krones A.
31.07 Directors' Dealings: Vonovia .
31.07 Mynaric stellt alle Geschäfts.
31.07 Stimmrechtsanteile: Epigenom.

Welche Social Networks nutzen Sie meistens?
Linked in

Stimmen: 94065 , Ergebnis

Status: nicht eingeloggt

Registrieren | Passwort vergessen?
Im Bereich Nachrichten:
Commerzbank: Kaufsignal bestätigt!
Experte: Stefan Hofmann, STOCK-WORLD
DOW DAX schliesst das ...
Thomas Heydrich, Systemstradings.de (17:49)
Experte: Thomas Heydrich, Systemstradings.de
Kreditversicherer Atradius ...
Stock-World Redaktion, STOCK-WORLD (17:08)
Experte: Stock-World Redaktion, STOCK-WORLD
Dow Jones - Die ersten ...
HypoVereinsbank onema., (17:05)
Experte: HypoVereinsbank onemarkets,
DAX macht 500-Punkte-...
CMC Markets, (17:05)
Experte: CMC Markets,
Wie Sie von Hochzeiten ...
Tea Muratovic, Seasonax Capital (17:02)
Experte: Tea Muratovic, Seasonax Capital
Borussia Dortmund ...
wikifolio.com, (14:43)
Experte: wikifolio.com,
DAX - Neue ...
Christian Zoller, www.boerse-daily.de (14:13)
Experte: Christian Zoller, www.boerse-daily.de
Technische Analyse zu ...
Miningscout.de, (14:11)
Experte: Miningscout.de,
FinTechs - Innovationen für ...
Feingold-Research, (14:07)
Experte: Feingold-Research,
Euwax Trends: Lufthansa ...
Cornelia Frey, Börse Stuttgart AG (14:05)
Experte: Cornelia Frey, Börse Stuttgart AG
Nikola: Lügen, Laster, ...
Achim Mautz, Obmann vom Börsenclub. (11:33)
Experte: Achim Mautz, Obmann vom Börsenclub ratgeberGELD
Pfizer-Calls nach Kaufsignal ...
Walter Kozubek, (11:05)
Experte: Walter Kozubek,
Niquet's World
Neues vom Portal
Beste Forex-Broker: 5 Top-Forex-Handelsplattformen
Letzte Börsen-Meldung
Letzte Börsen-Analyse
Top-Klicks News
Top-Klicks Analysen